PRESS RELEASE: Evotec receives pre-clinical milestone as part of its discovery alliance with Boehringer Ingelheim
PRESS RELEASE: Evotec receives pre-clinical milestone as part of its discovery alliance with Boehringer Ingelheim
DGAP-News: Evotec AG / Key word(s): Miscellaneous Evotec receives pre-clinical milestone as part of its discovery alliance with Boehringer Ingelheim
10.12.2013 / 07:29
=--------------------------------------------------------------------
Hamburg, Germany - 10 December 2013: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone in November triggering revenues of EUR 4.0 m to Evotec. The milestone was for the transition of an oncology molecule into pre-clinical development.
Dr Mario Polywka, Chief Operating Officer of Evotec commented: 'This is the twenty-first milestone achieved as part of our alliance with Boehringer Ingelheim and represents a third oncology compound transitioning into pre-clinical development of which one is already in Phase I clinical trials. Our collaboration with Boehringer Ingelheim continues to support Evotec's overall strategy of building up a pipeline of assets of which we have interest in future upside.'
ABOUT THE EVOTEC & BOEHRINGER INGELHEIM ALLIANCE In 2004, Evotec entered into a multi-year, multi-target drug discovery alliance with Boehringer Ingelheim to jointly identify and develop pre-clinical development candidates for the treatment of various disease areas including CNS, inflammation, cardiometabolic and respiratory diseases. In 2009, the collaboration was extended for an additional four years and the scope expanded to include oncology targets. Under the terms of the agreement, Boehringer Ingelheim has full ownership and global responsibility for clinical development, manufacturing and commercialisation of the compounds identified. In return, Evotec receives ongoing research payments and pre-clinical milestones. Furthermore, the contract provides substantial long-term upside for Evotec through potential payments for successful milestone achievements during clinical development and royalties when new drugs reach the market.
ABOUT EVOTEC AG Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca and Ono Pharmaceutical. In addition, the Company has existing development partnerships and product candidates both in clinical and pre-clinical development. These include partnerships with Boehringer Ingelheim, MedImmune and Andromeda (Teva) in the field of diabetes, with Janssen Pharmaceuticals in the field of depression and with Roche in the field of Alzheimer's disease. For additional information please go to http://www.evotec.com.
FORWARD LOOKING STATEMENTS - Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this report. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.
Contact Evotec AG: Gabriele Hansen, Head of Corporate Communications, Phone: +49.(0)40.56081-255, gabriele.hansen@evotec.com
Follow this link:
PRESS RELEASE: Evotec receives pre-clinical milestone as part of its discovery alliance with Boehringer Ingelheim
- Malaysia Airlines' lack of early word on missing plane angers many Beijing relatives - March 11th, 2014 [March 11th, 2014]
- PRESS RELEASE: Ekotechnika GmbH: Creditreform adjusts rating outlook to 'watch' - March 11th, 2014 [March 11th, 2014]
- PRESS RELEASE: Epigenomics and VSA receive approval to market Epi proColon in Argentina - March 11th, 2014 [March 11th, 2014]
- PRESS RELEASE: Ekosem-Agrar GmbH: Creditreform adjusts rating outlook to 'watch' - March 11th, 2014 [March 11th, 2014]
- PRESS RELEASE: YOUNIQ AG publishes preliminary consolidated net result for financial year 2013 - March 11th, 2014 [March 11th, 2014]
- PRESS RELEASE: technotrans AG: technotrans -2- - March 11th, 2014 [March 11th, 2014]
- Work From No Home Does It Work + Work From No Home Pdf - Video - March 9th, 2014 [March 9th, 2014]
- Kansas City-area spelling bee finally ends - March 9th, 2014 [March 9th, 2014]
- AP Exclusive: Man denies he's bitcoin creator - March 8th, 2014 [March 8th, 2014]
- Charges dropped against trio accused of using y-word slur - March 8th, 2014 [March 8th, 2014]
- PRESS RELEASE: DF Deutsche Forfait AG publishes preliminary 2013 financials - March 8th, 2014 [March 8th, 2014]
- Word Press Blog Unordered List With symbol - Video - March 6th, 2014 [March 6th, 2014]
- Who can use the N word? - March 6th, 2014 [March 6th, 2014]
- PRESS RELEASE: Manz AG returns to the TecDAX - March 6th, 2014 [March 6th, 2014]
- PRESS RELEASE: Ekotechnika GmbH rated B (outlook: stable) by Creditreform - March 6th, 2014 [March 6th, 2014]
- PRESS RELEASE: Ad hoc announcement: Rickmers bond increased to 250 million Euros - March 6th, 2014 [March 6th, 2014]
- Meyer, Widlitz Join GHS 'End the R-Word' Effort - March 6th, 2014 [March 6th, 2014]
- PRESS RELEASE: AURELIUS: Convincing preliminary figures for 2013 - March 5th, 2014 [March 5th, 2014]
- PRESS RELEASE: Epigenomics AG: Clinical study conducted in the Czech Republic confirms blood-based Septin9 test to be ... - March 5th, 2014 [March 5th, 2014]
- PRESS RELEASE: ORCO GERMANY S.A. raising EUR 36 million and seeks an additional EUR 36M through capital increase - March 5th, 2014 [March 5th, 2014]
- Press the President Celebrates International Women's Day - March 4th, 2014 [March 4th, 2014]
- PRESS RELEASE: Wacker Neuson SE: Wacker Neuson on the path to success despite weak market - March 4th, 2014 [March 4th, 2014]
- PRESS RELEASE: Cevian Capital AG: European Investor Cevian Capital Increases its Stake in ThyssenKrupp to 15.1 Percent - March 4th, 2014 [March 4th, 2014]
- PRESS RELEASE: Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine - March 4th, 2014 [March 4th, 2014]
- How to make money with a word press blog - Video - March 3rd, 2014 [March 3rd, 2014]
- Your Professional Word Press Site Cheap! - Video - March 3rd, 2014 [March 3rd, 2014]
- A Press Room salute to the memorable Tom Hall - March 3rd, 2014 [March 3rd, 2014]
- Foreign Office spurned free Press day 'to duck attack on Royal Charter' - March 3rd, 2014 [March 3rd, 2014]
- PRESS RELEASE: Geratherm Medical AG: New SRA Technology detects atrial fibrillation at an early stage and prevents ... - March 3rd, 2014 [March 3rd, 2014]
- PRESS RELEASE: Salzgitter AG: Key data for the financial year 2013 - Crisis in Europe's industry impacts the financial ... - March 2nd, 2014 [March 2nd, 2014]
- PRESS RELEASE: FUCHS increases sales revenues and earnings again in 2013 - February 28th, 2014 [February 28th, 2014]
- Proof press couldnt ask Ronan personal questions - February 28th, 2014 [February 28th, 2014]
- PRESS RELEASE: Nordex SE: Strong growth and return to profit in 2013 - February 28th, 2014 [February 28th, 2014]
- FABULOUSBEAUTIES - Video - February 27th, 2014 [February 27th, 2014]
- Word Press themes_09 - Video - February 27th, 2014 [February 27th, 2014]
- PRESS RELEASE: HOMAG Group increases net profit for the year by 45 percent - February 27th, 2014 [February 27th, 2014]
- PRESS RELEASE: Allianz SE: Allianz finishes -2- - February 27th, 2014 [February 27th, 2014]
- Word Press Page Editing - Video - February 27th, 2014 [February 27th, 2014]
- Op-ed: Go Ahead and Call Me What You Want - February 27th, 2014 [February 27th, 2014]
- PRESS RELEASE: Gerry Weber confirms international growth strategy - February 27th, 2014 [February 27th, 2014]
- Borges: N-word a lost debate - February 27th, 2014 [February 27th, 2014]
- PRESS RELEASE: DAB Bank generated strong operating growth in financial year 2013 - February 27th, 2014 [February 27th, 2014]
- "Freeway2Success" Launches "Recipes4YourSuccess" Making Money Blogging and YouTube! - Video - February 25th, 2014 [February 25th, 2014]
- Video Tutorial Blog Word Press. Christian Carrera Cabrera - Video - February 25th, 2014 [February 25th, 2014]
- PRESS RELEASE: WILEX AG: Professor Olaf G. Wilhelm leaves the Executive Management Board on 31 March 2014, Dr Jan ... - February 25th, 2014 [February 25th, 2014]
- PRESS RELEASE: QSC AG takes over encryption specialist FTAPI - February 25th, 2014 [February 25th, 2014]
- PRESS RELEASE: SolarWorld AG successfully closes financial restructuring - February 25th, 2014 [February 25th, 2014]
- PRESS RELEASE: CASSONA SE: CASSONA's oil property contains about 50.8 million barrel light oil and about 102.6 million ... - February 25th, 2014 [February 25th, 2014]
- PRESS RELEASE: PNE WIND AG receives approval for the UK wind farm project Tralorg - February 22nd, 2014 [February 22nd, 2014]
- site template Cherry - Responsive News and Magazine Theme Download - Video - February 20th, 2014 [February 20th, 2014]
- PRESS RELEASE: TAKKT: Solid operating key figures -2- - February 20th, 2014 [February 20th, 2014]
- PRESS RELEASE: Ferratum Group: Starting signal in Germany and Romania - February 20th, 2014 [February 20th, 2014]
- PRESS RELEASE: Grammer AG with new record in 2013 - February 20th, 2014 [February 20th, 2014]
- PRESS RELEASE: Elmos Semiconductor AG: Strong final quarter 2013 sets sales record - February 20th, 2014 [February 20th, 2014]
- PRESS RELEASE: FAST Casualwear AG receives another large order from Europe - February 19th, 2014 [February 19th, 2014]
- Google's Official Word: Don't Be a Glasshole - February 19th, 2014 [February 19th, 2014]
- PRESS RELEASE: comdirect: pre-tax profit of EUR 80.0m - 2.83 million customers - dividend proposal of 36 cents per share - February 19th, 2014 [February 19th, 2014]
- PRESS RELEASE: Intershop reports licensing revenues up 20% in financial year 2013 - February 19th, 2014 [February 19th, 2014]
- PRESS RELEASE: NORMA Group generates record sales and earnings in 2013 - February 19th, 2014 [February 19th, 2014]
- PRESS RELEASE: euromicron AG: Future-proof DMR solution - February 18th, 2014 [February 18th, 2014]
- " Central Africa, We are with you" Muslim Thoughts on Central African Republic Conflict. - Video - February 18th, 2014 [February 18th, 2014]
- PRESS RELEASE: Changes to the Management Board of centrotherm photovoltaics AG - February 18th, 2014 [February 18th, 2014]
- PRESS RELEASE: Grand City Properties S.A., : successfully places EUR 150 million convertible bonds - February 18th, 2014 [February 18th, 2014]
- Snippet "Don't Tell me You did know" Ep 1 "Black History Month and the untold story - Video - February 17th, 2014 [February 17th, 2014]
- PRESS RELEASE: Grand City Properties S.A. launches a convertible bond offering - February 17th, 2014 [February 17th, 2014]
- PRESS RELEASE: Dr. Claus Vielsack appointed member of the management board of STRATEC for Product Development - February 17th, 2014 [February 17th, 2014]
- PRESS RELEASE: ENTRADE Energiesysteme AG presents plants generating energy from wood at bio-energy conference in Moscow - February 17th, 2014 [February 17th, 2014]
- PRESS RELEASE: Hoeft & Wessel exhibits ticketing solutions portfolio at IT-Trans trade fair (news with additional ... - February 17th, 2014 [February 17th, 2014]
- How To Put An Opt-In Form In Word Press - Video - February 15th, 2014 [February 15th, 2014]
- All-Star Event 2014 | Iphone 7.1 Beta 5 - Video - February 15th, 2014 [February 15th, 2014]
- video ne di lebokne word press - Video - February 15th, 2014 [February 15th, 2014]
- PRESS RELEASE: Standard & Poor's Ratings Services raised Grand City Properties S.A. rating to 'BB+' based on stronger ... - February 15th, 2014 [February 15th, 2014]
- A word is anything I say it means - February 15th, 2014 [February 15th, 2014]
- Press freedom: Why does the govt keep shooting itself in the foot? - February 15th, 2014 [February 15th, 2014]
- PRESS RELEASE: NORMA Group holds 100% of shares in Chien Jin Plastic, Malaysia - February 10th, 2014 [February 10th, 2014]
- PRESS RELEASE: Prime Office AG: Individual shareholders initiated special proceedings - February 10th, 2014 [February 10th, 2014]
- PRESS RELEASE: Mensch und Maschine Software SE discloses preliminary 2013 figures - February 10th, 2014 [February 10th, 2014]
- PRESS RELEASE: TAG Immobilien AG announces EUR 110m increase in its 2013/2018 corporate bond - February 10th, 2014 [February 10th, 2014]
- PRESS RELEASE: Epigenomics AG: Epigenomics Further Strengthens Intellectual Property Coverage for Epi proColon in the ... - February 10th, 2014 [February 10th, 2014]
- Sage Kotsenburg Stoked at Sochi - February 10th, 2014 [February 10th, 2014]